HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are living with HIV.
- People who are living in a fishing community on most days or nights.
- People who screen positive for potentially harmful drinking habits based on a standard questionnaire (a score of 4 or higher on a tool called the AUDIT-C).
- People who have been on HIV treatment (antiretroviral therapy) for more than 6 months.
- People who are not planning to move away from the area within the next 6 months.
- People who own a mobile phone and can be contacted by phone.
- People who show a sign that their HIV treatment may not be working as well as it should, meaning one of the following applies: their most recent HIV viral load test (taken within the last 6 months) showed the virus was detectable; OR their last viral load test was between 6 and 13 months ago, showed the virus was detectable, and they report missing 2 or more doses of HIV medication in the past 2 weeks; OR clinic records show no viral load test in the past 13 months, and they report missing 2 or more doses of HIV medication in the past 2 weeks.
Who may not be able to join:
- People who appear visibly intoxicated at the time of enrollment (though they may be considered again when not intoxicated).
- People who do not speak Luganda or English.
- People who currently receive most of their work payments through mobile money or other digital payment methods.
- People who took part in a previous related study called the Kisoboka pilot trial.
- People who are unable to read basic Luganda or English.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Susan M Kiene, PhD, MPH, San Diego State University
Phone: +256 414 543872
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Phosphatidylethanol (PEth) From Baseline; Number of Participants with very Hazardous Alcohol Use at Baseline, 6, and 12 Month Follow up; Number of Participants With Optimal Antiretroviral (ART) Adherence at Baseline, 6 and 12 Month Follow up; Number of Participants with Undetectable HIV Viral Loads at baseline, 6, and 12 month follow up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.